1. Clinical Overview
Secnidazole is a second-generation 5-nitroimidazole antimicrobial agent with potent activity against anaerobic bacteria and protozoa. It is characterized by a long plasma half-life, allowing for single-dose or short-course therapy, which significantly improves patient compliance. It is a prodrug that requires intracellular activation by susceptible organisms.
| Onset | Duration | Bioavailability |
|---|---|---|
| Peak plasma concentration (Tmax) is achieved in 1-3 hours. | Therapeutic concentrations are maintained for 24-48 hours post a single 1000mg dose, allowing for once-daily or single-dose regimens. | Approximately 90-100% following oral administration. |
2. Mechanism of Action
Secnidazole is a prodrug. Its nitro group is reduced intracellularly by nitroreductase enzymes (ferredoxin or flavodoxin systems) found in anaerobic bacteria and protozoa. This reduction generates cytotoxic intermediates (nitroso and hydroxylamine derivatives) that cause DNA damage. These intermediates form unstable adducts with DNA, leading to strand breakage, inhibition of nucleic acid synthesis, and ultimately cell death.
3. Indications & Uses
- Amoebiasis (intestinal and hepatic)
- Giardiasis (Lambliasis)
- Bacterial vaginosis (BV)
- Trichomoniasis (urogenital)
- Anaerobic bacterial infections (e.g., those caused by Bacteroides spp., Clostridium spp., Peptostreptococcus)
4. Dosage & Administration
Adult Dosage: Amoebiasis/Giardiasis: 1000mg as a single dose or 500mg twice daily for 5-7 days. Bacterial Vaginosis/Trichomoniasis: 1000mg as a single dose. Anaerobic Infections: 1000mg once daily for 5-7 days.
Administration: Take orally with or after food to minimize gastrointestinal upset. The tablet should be swallowed whole with a full glass of water. For single-dose therapy in BV/Trichomoniasis, sexual partners should be treated concurrently to prevent re-infection.
5. Side Effects
Common side effects may include:
- Nausea
- Metallic/bitter taste in mouth
- Headache
- Dizziness
- Abdominal discomfort
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Alcohol (Ethanol) | Disulfiram-like reaction: flushing, palpitations, nausea, vomiting, headache. | Major |
| Warfarin and other Coumarin anticoagulants | Secnidazole may potentiate anticoagulant effect, increasing INR and risk of bleeding. | Major |
| Lithium | May increase lithium serum levels and risk of toxicity. | Moderate |
| Phenobarbital, Phenytoin | May increase metabolism of secnidazole, reducing its efficacy. | Moderate |
| Cyclosporine, Tacrolimus | Potential increase in calcineurin inhibitor levels; monitor levels. | Moderate |
7. Patient Counselling
- DO complete the full course as prescribed, even if you feel better.
- DO take the medicine with food.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO NOT consume any alcohol (beer, wine, spirits) or products containing alcohol (cough syrups, tonics) during treatment and for at least 3 days after the last dose.
- DO NOT drive or operate heavy machinery if you experience dizziness.
8. Toxicology & Storage
Overdose: Nausea, vomiting, ataxia, seizures, peripheral neuropathy. No specific acute toxicity pattern from massive overdose is well documented.
Storage: Store below 30°C, in a cool, dry place. Protect from light and moisture. Keep out of reach of children.